Hepatitis C Virus Infection is a Risk Factor for Non-Hodgkin Lymphoma: A MOOSE-compliant Meta-Analysis

Xiaofeng Zhu,Li Jing,Xiaoming Li
DOI: https://doi.org/10.1097/md.0000000000014755
IF: 1.6
2019-01-01
Medicine
Abstract:Previous studies have reached conflicting results regarding the possibility that hepatitis C virus (HCV) infection may increase the risk of non-Hodgkin lymphoma (NHL). We performed a meta-analysis to clarify the relationship between HCV infection and development of NHL. The PubMed, Web of Science, and Embase databases were searched for relevant studies estimating the association between HCV infection and NHL risk through October 31, 2017. Fixed effects or random effects models were used to calculate the pooled odds ratio (OR) and its 95% confidence interval (CI). A total of 18 studies met the inclusion criteria. We found a positive association between HCV infection and NHL (pooled OR 1.69, 95% CI 1.40-2.03, P<.05). In conclusion, our meta-analysis suggested that HCV infection was associated with increased risk of developing NHL.
What problem does this paper attempt to address?